These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24279796)

  • 1. Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
    Kinoshita J; Takahashi Y; Watabe AM; Utsunomiya K; Kato F
    Mol Pain; 2013 Nov; 9():59. PubMed ID: 24279796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1.
    Morgado C; Silva L; Pereira-Terra P; Tavares I
    Neurobiol Dis; 2011 Jul; 43(1):275-84. PubMed ID: 21515376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine in diabetic neuropathy.
    Smith TR
    Expert Opin Pharmacother; 2006 Feb; 7(2):215-23. PubMed ID: 16433585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy.
    Murai N; Aoki T; Tamura S; Yamamoto H; Hamakawa N; Matsuoka N
    Neuropharmacology; 2014 Apr; 79():10-6. PubMed ID: 24211301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
    Mixcoatl-Zecuatl T; Jolivalt CG
    Br J Pharmacol; 2011 Sep; 164(1):159-69. PubMed ID: 21410686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Duloxetine on the Toll-Like Receptor 4 Signaling Pathway in Spinal Dorsal Horn in a Rat Model of Diabetic Neuropathic Pain.
    Zhou DM; Zhuang Y; Chen WJ; Li W; Miao B
    Pain Med; 2018 Mar; 19(3):580-588. PubMed ID: 28575508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test.
    Munro G
    Eur J Pharmacol; 2007 Dec; 575(1-3):66-74. PubMed ID: 17725928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin attenuates increase of synaptic number in the rat spinal dorsal horn with painful diabetic neuropathy induced by type 2 diabetes: a stereological study.
    Lin JY; He YN; Zhu N; Peng B
    Neurochem Res; 2018 Dec; 43(12):2232-2239. PubMed ID: 30306321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.
    Kuhad A; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Mar; 47(3):193-7. PubMed ID: 19405385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
    Smith T; Nicholson RA
    Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Administration of Amitriptyline in Neuropathic Pain: Modulation of the Noradrenergic Descending Inhibitory System.
    Hiroki T; Suto T; Saito S; Obata H
    Anesth Analg; 2017 Oct; 125(4):1281-1288. PubMed ID: 28787345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperalgesic effect of duloxetine and amitriptyline in rats after peripheral nerve injury: Influence of descending noradrenergic plasticity.
    Hoshino H; Obata H; Saito S
    Neurosci Lett; 2015 Aug; 602():62-7. PubMed ID: 26135544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
    Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy.
    Niknia S; Kaeidi A; Hajizadeh MR; Mirzaei MR; Khoshdel A; Hajializadeh Z; Fahmidehkar MA; Mahmoodi M
    Neuropeptides; 2019 Feb; 73():34-40. PubMed ID: 30447858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-derived peptide is an effective target for treating streptozotocin induced painful diabetic neuropathy through induction of activated protein kinase/peroxisome proliferator-activated receptor gamma coactivator 1alpha -mediated mitochondrial biogenesis.
    Xu L; Tang X; Yang L; Chang M; Xu Y; Chen Q; Lu C; Liu S; Jiang J
    Mol Pain; 2024; 20():17448069241252654. PubMed ID: 38658141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Administration of Duloxetine Suppresses Neuropathic Pain by Accumulating Effects of Noradrenaline in the Spinal Cord.
    Ito S; Suto T; Saito S; Obata H
    Anesth Analg; 2018 Jan; 126(1):298-307. PubMed ID: 28787337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA Improves Painful Diabetic Neuropathy by Suppressing the Expression and Activity of Voltage-Gated Sodium Channel in Rat Dorsal Root Ganglia.
    Ri-Ge-le A; Guo ZL; Wang Q; Zhang BJ; Kong DW; Yang WQ; Yu YB; Zhang L
    Exp Clin Endocrinol Diabetes; 2018 Nov; 126(10):632-639. PubMed ID: 29388177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Over-Expressing of microRNA-145 Effectively Precludes the Development of Neuropathic Mechanical Hyperalgesia via Suppressing Nav1.8 in Diabetic Rats.
    Yan J; Yu H; Shen J; Han C; Li C; Shen X; Li B
    Pain Physician; 2020 Nov; 23(6):E673-E686. PubMed ID: 33185386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.
    Sultan A; Gaskell H; Derry S; Moore RA
    BMC Neurol; 2008 Aug; 8():29. PubMed ID: 18673529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.
    Wernicke JF; Prakash A; Kajdasz DK; Houston J
    J Diabetes Complications; 2009; 23(5):349-59. PubMed ID: 18768332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.